Analyst Ratings for Nephros (NEPH)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
5/9/2022 | Benchmark | Robert Wasserman | Downgrade | Hold (Speculative Buy) |
N/A (N/A) |
2.21 (2.19) |
-0.9% | Details |
1/26/2021 | B.Riley » Updated 5/5/2022 |
Marc Wiesenberger | New Coverage | Buy (N/A) |
5.25 (8.00) |
7.80 (2.19) |
-71.92% | Details |
![]() |